Singapore bets on driverless future

nuTonomy is currently testing six vehicles and is aiming for the commercial launch of its on-demand robo-taxi service in Singapore next year. Kyodo News reporters recently took a ride in an autonomous car that is being tested by Smart (Singapore-MIT ... ( read original story ...)

I’m a banking recruiter in Asia. Here’s how to keep me happy

You really need to be on my good side. http://news.efinancialcareers.com/sg-en/235989/ideal-employer-asia-top-10/ It’s the busy(ish) season for hiring in the Singapore banking sector. Finance professionals have their bonuses and some are sending resumes ... ( read original story ...)

HDB loan vs bank loan

However, CPF rates do not change often. For bank loans, things get a bit more complicated. Bank loans can be based on the Singapore Interbank Offered Rate (SIBOR), Swap Offer Rate (SOR), or a bank’s Internal Board Rate (IBR), of which Fixed Deposit Home ... ( read original story ...)

UnUsUaL IPO

UnUsUalL IPO will be the next Singapore IPO for retail and institutional investors. MM2 Asia announced on 4 April 2017 that it would launch the IPO shares of its unit UnUsUaL. Some 97 million shares at $0.20 per share would be placed. I believe UnUsUaL IPO ... ( read original story ...)

Strong global IPO activity in Q1: EY

Max Loh, EY ASEAN and Singapore managing partner, Ernst & Young LLP, said that IPO activity in Asia-Pacific has been powering ahead due to the region's relative insulation from political uncertainty elsewhere in the world, ample liquidity in emerging ... ( read original story ...)

Singapore Morning News For April 19

This is part of an initial public offering (IPO) to raise S$11.4 million ($8.17 million ... ANYONE visiting the National University of Singapore (NUS) early next year might be treated to the sight of drones flying across the campus, delivering small ... ( read original story ...)

Taiwan draws foreign biotech IPOs

Aslan had weighed a US IPO, among various options ... The company will continue to be headquartered in Singapore but has invested in expanding in Taiwan. Aslan’s experimental drug Varlitinib, a potential treatment for bile duct cancer, is in late ... ( read original story ...)